NephLong
Esoprex Capsule
Details
20 mg
40 mg
Product Name: Esoprex Capsule (Enteric Coated)
Generic Name: Esomeprazole
Product Description:
Esoprex Capsule is an enteric-coated formulation of Esomeprazole, a proton pump inhibitor (PPI). It reduces gastric acid secretion by selectively inhibiting the H+/K+-ATPase enzyme system at the surface of the gastric parietal cell. The enteric coating protects the drug from degradation by stomach acid, ensuring it is released in the intestines for optimal absorption.
Available Strengths:
-
Esoprex 20 mg
-
Esoprex 40 mg
Indications:
-
Gastroesophageal Reflux Disease (GERD)
-
Erosive Esophagitis
-
Zollinger-Ellison Syndrome
-
Peptic Ulcer Disease (especially associated with H. pylori)
-
NSAID-induced gastric ulcers
Dosage:
| Indication | Typical Adult Dose |
|---|---|
| GERD (non-erosive) | 20 mg once daily for 4–8 weeks |
| Erosive Esophagitis | 40 mg once daily for 4–8 weeks |
| Maintenance of healing (GERD) | 20 mg once daily |
| H. pylori eradication (with antibiotics) | 20 mg twice daily for 10–14 days |
| NSAID-induced ulcer prevention | 20 mg once daily |
| Zollinger-Ellison Syndrome | 40 mg twice daily (adjust as needed) |
Keto Nephron™ DS is a Medical Food as defined under 21 U.S.C. §360ee(b)(3) and 21 CFR 101.9(j)(8), formulated for the dietary management of Chronic Kidney Disease (CKD) Stages 3-5 in adults following physician-supervised protein-restricted diets. It is not a drug, not a dietary supplement, and is not intended for self-medication or general wellness use. MUST BE USED UNDER MEDICAL SUPERVISION. Quantum LifeSciences Inc., Claremont, CA 91711, USA. FDA Food Facility (Manufacturer) Reg. No. 14961463490.